临床药理学 临床药理学
Severin B Vogt1, Matthias E Liechti1
1Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.
International review of neurobiology
|June 20, 2025
概括
了解psilocybin和MDMA等迷幻药物的临床药理学是治疗试验的关键. 虽然迷幻药通过5-HT2A受体具有相似的效果,但它们的药理动力学不同,影响治疗用途.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
- 精神活性物质 精神活性物质
背景情况:
- 临床药理学对于设计治疗试验和选择适当的药物剂量至关重要.
- 最近的研究重点是心理学和MDMA的人类药理学.
- 了解这些物质对于推进其临床应用至关重要.
研究的目的:
- 总结各种类固醇类精神药物和MDMA的药理学特征.
- 审查现代临床试验中关于作用机制,药理动力学,药理动力学,新陈代谢和安全性的人类数据.
- 为剂量,剂量调整和药物相互作用提供建议.
主要方法:
- 对现有文学和临床试验数据的审查 关于 псилоцибин,LSD,梅斯卡林,DMT,5-MeO-DMT和MDMA.
- 对药理学特征的分析,包括受体相互作用,药理动力学-药理动力学关系和耐受性.
- 安全数据和临床建议的综合.
主要成果:
- 血清色精神药物 (psilocybin,LSD,mescaline,DMT,5-MeO-DMT) 通过5-HT2A受体相互作用产生类似的急性作用,但在药理动力学和代谢方面有所不同,影响作用的持续时间.
- MDMA具有独特的特征,具有类似兴奋剂和同情效应,并表现出急性药物耐受性,与迷幻药不同.
- 尽管有类似的急性作用,但迷幻药的治疗益处需要进一步阐明.
结论:
- 对经典迷幻药物和MDMA的药理学有全面的了解,是它们临床使用和有效治疗试验的设计的基础.
- 迷幻药物之间药理动力学和新陈代谢的差异需要仔细考虑特定的治疗指示.
- 与经典迷幻药相比,MDMA独特的精神药理学特征和耐受性表明其具有独特的治疗应用.
相关概念视频
Pharmacodynamics: Overview and Principles
2.2K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.2K
Preclinical Development: Overview
4.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.9K
Biopharmaceutics and Pharmacokinetics: Overview
2.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.6K
Nonlinear Pharmacokinetics: Overview
573
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
573
Pharmacokinetics: Overview
7.2K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
7.2K
Drug Administration and Therapy Phases: Overview
779
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
779


